Global Nanomedicine Market is anticipated to reach USD 350.8
billion by 2025, according to a new report by Grand View Research, Inc.
Development of novel nanotechnology-based drugs and therapies is driven by the
need to develop therapies that have fewer side effects and that are more
cost-effective than traditional therapies, in particular for cancer.
Application of nanotechnology-based contrast reagents for
diagnosis and monitoring of the effects of drugs on an unprecedented short
timescale is also attributive drive growth in the coming years. Additionally,
demand for biodegradable implants with longer lifetimes that enable tissue
restoration is anticipated to influence demand.
As per the WHO factsheet, cancer is found to be one of the
major causes of mortality and morbidity worldwide, with approximately 14
million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand
for nanomedicine in order to curb such high incidence rate is expected to boost
market progress during the forecast period.
Solutions such as nanoformulations with triggered release
for tailor-made pharmacokinetics, nanoparticles for local control of tumor in
combination with radiotherapy, and functionalized nanoparticles for targeted
in-vivo activation of stem cell production are anticipated to drive R&D,
consequently resulting in revenue generation in the coming years.
Biopharmaceutical and medical devices companies are actively
engaged in development of novel products as demonstrated by the increasingly
growing partnerships between leading enterprises and nanomedicine startups. For
instance, in November 2015, Ablynx and Novo Nordisk signed a global
collaboration and a licensing agreement for development and discovery of
innovative drugs with multi-specific nanobodies. This strategic partnership is
anticipated to rise the net annual sales of the products uplifting the market
growth.
However, in contrary with the applications of nanotechnology,
the entire process of lab to market approval is a tedious and expensive one
with stringent regulatory evaluation involved thereby leading investors to
remain hesitant for investments.
Access Full Research Report on Global Nanomedicine
Market:
http://www.grandviewresearch.com/industry-analysis/nanomedicine-market
http://www.grandviewresearch.com/industry-analysis/nanomedicine-market
Further key findings from the report suggest:
- Therapeutics
accounted for the largest share of market revenue in 2016 owing to
presence of nanoemulsions, nanoformulations, or nanodevices
- These
devices possess the ability to cross biological barriers. Moreover,
presence of drugs such as Doxil, Abraxane, and Emend is attributive for
higher revenue generation
- Presence
of substantial number of products manufactured through the use of
microbial sources can be attributed for the largest share
- In-vitro diagnostics
is expected to witness lucrative progress as a result of R&D carried
out in this segment
- Introduction
of nano-enabled biomarkers, vectors and contrast agents with
high-specificity and sensitivity are attributive for projected progress
- Clinical
cardiology is expected to witness the fastest growth through to 2025 owing
to development in nano-functionalization and modification of surfaces for
increased biocompatibility of implants in treatment of late thrombosis
- Moreover,
an abundance of research publications and patent filings from European
region with a share of about 25% in nanomedicine-related publications is
supportive for revenue generation from European economies
- Asia
Pacific is estimated to witness the fastest growth over the forecast
period
- Factors
responsible include government and regulatory authorities that have
implemented a framework to encourage R&D collaborations and framework
extension.
- Key
players operating in this industry include Pfizer Inc., Ablynx NV,
Nanotherapeutics Inc., Nanoviricides Inc., Abraxis Inc., Arrowhead
Research Inc., Celgene Corporation, Bio-Gate AG, and Merck
- Active
expansion strategies are undertaken by a number of the major market
entities in order to strengthen their position
- North
America dominated the industry in 2016, accounting for a 42% of total
revenue
- Presence
of key participants operating in the region are involved in collaborative
activities are attributive for the largest share of North America in
sector revenue
View more reports of
this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research
has segmented the Global Nanomedicine Market on the basis of product,
application, nanomolecule type, and region:
Nanomedicine Product Outlook (Revenue, USD Billion;
2013 - 2025)
- Therapeutics
- Regenerative
medicine
- In-vitro
diagnostics
- In-vivo
diagnostics
- Vaccines
Nanomedicine Application Outlook (Revenue, USD Billion;
2013 - 2025)
- Clinical
Oncology
- Infectious
diseases
- Clinical
Cardiology
- Orthopedics
- Others
Nanomedicine Nanomolecule Type Outlook (Revenue, USD
Billion; 2013 - 2025)
- Nanoparticles
- Metal
& Metal Oxide Nanoparticles
§
By Type
·
Gold Nanoparticles
·
Silver Nanoparticles
·
Iron Oxide Nanoparticles
·
Alumina Nanoparticles
·
Gadolinium Oxide Nanoparticles
·
Others
§
By Application
·
In-vivo Imaging
·
Targeted Drug Delivery
·
Proton Therapy
·
In-vitro assays
·
Cell & Phantom Imaging
·
Liposomes
·
Polymers & polymer drug conjugates
·
Hydrogel nanoparticles
·
Dendrimers
·
Inorganic nanoparticles
·
Nanoshells
·
Nanotubes
·
Nanodevices
Nanomedicine Regional Outlook (Revenue, USD Billion; 2013
- 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Middle
East and Africa (MEA)
- South
Africa
View
Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-nanomedicine-market
About
Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more Information visit us: www.grandviewresearch.com
